Vitrolife AB (publ) (STO:VITR)
Sweden
· Delayed Price · Currency is SEK 156.10
+0.60 (0.39%)
Apr 15, 2025, 3:00 PM CET
Vitrolife AB Company Description
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits.
The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp.
Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.
Vitrolife AB (publ)
| Country | Sweden |
| Founded | 1989 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,169 |
| CEO | Bronwyn Brophy O´Connor |
Contact Details
Address: Gustaf Werners gata 2 Gothenburg, 421 32 Sweden | |
| Phone | 46 31 721 80 00 |
| Website | vitrolife.com |
Stock Details
| Ticker Symbol | VITR |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0011205202 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Bronwyn Brophy O´Connor | Chief Executive Officer and President |
| Helena Wennerström | Acting Chief Financial Officer |
| Ermanno Sironi | Chief Operating Officer |
| Claus Bisgaard | Senior Vice President of Technologies |